NAV1 - neuron navigator 1 Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102141619
NAV1 Products (10)
| mRNA | Protein | Name |
|---|---|---|
| XM_005540404.3 | XP_005540461.1 | neuron navigator 1 isoform X1 |
| XM_015447945.2 | XP_015303431.1 | neuron navigator 1 isoform X2 |
| XM_015447948.2 | XP_015303434.1 | neuron navigator 1 isoform X3 |
| XM_015447949.2 | XP_015303435.1 | neuron navigator 1 isoform X4 |
| XM_015447953.2 | XP_015303439.1 | neuron navigator 1 isoform X5 |
| XM_015447954.2 | XP_015303440.1 | neuron navigator 1 isoform X6 |
| XM_015447959.2 | XP_015303445.1 | neuron navigator 1 isoform X7 |
| XM_015447962.2 | XP_015303448.1 | neuron navigator 1 isoform X8 |
| XM_045363652.1 | XP_045219587.1 | neuron navigator 1 isoform X9 |
| XM_015447966.2 | XP_015303452.1 | neuron navigator 1 isoform X10 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
neuron navigator 1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-148800 | Suzetrigine | Inhibitor | 99.98% | Unkown |
| HY-17429 | Flecainide acetate | Inhibitor | 99.35% | Unkown |
| HY-17355A | Dexpramipexole dihydrochloride | 99.94% | Yes | |
| HY-B0262 | Methocarbamol | Inhibitor | 99.68% | Unkown |
| HY-17355B | Dexpramipexole | 99.56% | Yes | |
| HY-17355AR | Dexpramipexole dihydrochloride (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(20)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-148410A | Zorevunersen sodium | Activator | 99.27% | Phase 3 |
| HY-105285 | Piromelatine | 99.70% | Phase 3 | |
| HY-148410 | Zorevunersen | Activator | / | Phase 3 |
| HY-12883 | PF 05089771 | Inhibitor | 99.87% | Phase 2 |
| HY-147423 | Zandatrigine | Inhibitor | 99.28% | Phase 2 |
| HY-12796A | Raxatrigine hydrochloride | Inhibitor | 99.10% | Phase 2 |
| HY-12796 | Raxatrigine | Inhibitor | 99.85% | Phase 2 |
| HY-16723 | Funapide | Inhibitor | 99.83% | Phase 2 |
| HY-131182 | DS-1971a | Inhibitor | 99.30% | Phase 2 |
| HY-105283 | PF 04531083 | Antagonist | 99.62% | Phase 2 |
| HY-125079 | DSP-2230 | Inhibitor | 98.33% | Phase 1 |
| HY-114237 | GDC-0276 | Inhibitor | 99.69% | Phase 1 |
| HY-139081 | GDC-0310 | Inhibitor | 98.84% | Phase 1 |
| HY-103623 | PF-05241328 | Inhibitor | 98.08% | Phase 1 |
| HY-114301 | PF-06305591 | Inhibitor | 99.74% | Phase 1 |
| HY-101383 | PF-01247324 | Inhibitor | 99.77% | Phase 1 |
| HY-122001 | PF-05186462 | Inhibitor | 99.69% | Phase 1 |
| HY-114301A | PF-06305591 dihydrate | Inhibitor | 99.84% | Phase 1 |
| HY-128794 | PF-05150122 | / | Phase 1 | |
| HY-W040555 | Norquetiapine dihydrochloride | 99.91% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(172)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N6691 | Veratridine | Inhibitor | 99.42% | Unkown |
| HY-100001 | SKF-96365 (hydrochloride) | 99.93% | Unkown | |
| HY-11079 | A-803467 | Inhibitor | 99.69% | Unkown |
| HY-100345 | AMTB hydrochloride | Inhibitor | 99.08% | Unkown |
| HY-16787 | ICA-121431 | Inhibitor | 99.35% | Unkown |
| HY-12811 | PF-04856264 | Inhibitor | 99.29% | Unkown |
| HY-118952A | PF-06456384 trihydrochloride | Inhibitor | 99.38% | Unkown |
| HY-P1221A | ProTx II TFA | Inhibitor | 99.86% | Unkown |
| HY-107405 | TC-N 1752 | Inhibitor | 99.67% | Unkown |
| HY-157802 | LTGO-33 | Inhibitor | 98.83% | Unkown |
| HY-126429 | Nav1.1 activator 1 | Activator | 98.98% | Unkown |
| HY-B0824 | Bifenthrin | Activator | 99.76% | Yes |
| HY-148792 | Relutrigine | Inhibitor | 99.33% | Unkown |
| HY-157786 | XPC-5462 | Inhibitor | 99.65% | Unkown |
| HY-100727 | AM-2099 | Inhibitor | 98.37% | Unkown |
| HY-164795A | SBI-810 hydrochloride | 99.55% | Unkown | |
| HY-W052508 | Norquetiapine | 99.95% | Unkown | |
| HY-157784 | XPC-7724 | Inhibitor | 99.46% | Unkown |
| HY-133012 | GFB-8438 | Inhibitor | 99.74% | Unkown |
| HY-171244 | Sodium Channel inhibitor 6 | Inhibitor | 99.93% | Unkown |
| HY-110325 | PF-04885614 | Inhibitor | 97.00% | Unkown |
| HY-B1837 | Cyfluthrin | Inhibitor | 99.52% | Unkown |
| HY-P10234A | Poneratoxin acetate | Modulator | 98.35% | Unkown |
| HY-19958 | XEN907 | Inhibitor | 98.74% | Unkown |
| HY-139346 | VX-150 | Inhibitor | 98.36% | Unkown |
| HY-133910 | Lu AE98134 | Activator | 98.07% | Unkown |
| HY-13985 | Nav1.7 inhibitor | Inhibitor | 99.63% | Unkown |
| HY-112279 | GNE-131 | Inhibitor | 98.15% | Unkown |
| HY-131870 | GX-201 | Inhibitor | 98.46% | Unkown |
| HY-145169 | AZ194 | Inhibitor | 99.45% | Unkown |
| HY-152166 | NaV1.2/1.6 channel blocker-1 | Inhibitor | / | Unkown |
| HY-125928 | AA43279 | Inhibitor | 99.80% | Unkown |
| HY-101789 | Nav1.7-IN-3 | Inhibitor | 98.21% | Unkown |
| HY-123824 | GNE-0439 | Inhibitor | 99.80% | Unkown |
| HY-155635 | Nav1.8-IN-4 | Inhibitor | 99.78% | Unkown |
| HY-20362 | 4-Azaindole | 99.57% | Unkown | |
| HY-N0478 | Neoline | 98.0% | Unkown | |
| HY-N1847 | 3'-Methoxydaidzein | Inhibitor | 99.67% | Unkown |
| HY-128772 | XPC-6444 | Inhibitor | 98.93 | Unkown |
| HY-157802A | (S)-LTGO-33 | Inhibitor | 99.41% | Unkown |
| HY-P1220A | Huwentoxin-IV TFA | Inhibitor | 99.18% | Unkown |
| HY-119934 | NaV1.7 inhibitor-1 | Inhibitor | 99.17% | Unkown |
| HY-123825 | GX-674 | Antagonist | 98.45% | Unkown |
| HY-143481 | Nav1.8-IN-2 | Inhibitor | 99.83% | Unkown |
| HY-P1218B | Phrixotoxin 3-NH2 TFA | Inhibitor | 98.96% | Unkown |
| HY-148410C | Zorevunensen negative control | Activator | 99.28% | Unkown |
| HY-12883A | PF-05198007 | Inhibitor | 99.27% | Unkown |
| HY-146069 | ABBV-318 | Inhibitor | 98.72% | Unkown |
| HY-125942 | SKF-96365 | 99.97% | Unkown | |
| HY-156596 | Aneratrigine | Inhibitor | 99.60% | Unkown |
| HY-178281 | E0199 | 99.89% | Unkown | |
| HY-P5807A | Cn2 toxin TFA | Agonist | 96.59% | Unkown |
| HY-155058 | Nav1.3 channel inhibitor 1 | Inhibitor | 99.11% | Unkown |
| HY-164795 | SBI-810 | 98.25% | Unkown | |
| HY-178494 | Nav1.7-IN-19 | Inhibitor | 98.87% | Unkown |
| HY-P1073 | ProTx-I | Inhibitor | 95.15% | Unkown |
| HY-P1441A | Mambalgin 1 TFA | Inhibitor | 95.72% | Unkown |
| HY-P1681A | GpTx-1 TFA | Antagonist | 99.56% | Unkown |
| HY-18689 | SYM2206 | Antagonist | 99.83% | Unkown |
| HY-108425B | (Rac)-AMG8379 | Antagonist | 99.25% | Unkown |
| HY-16723A | (R)-Funapide | Inhibitor | 99.22% | Unkown |
| HY-123414 | GX-936 | Inhibitor | 97.06% | Unkown |
| HY-15736 | Sodium Channel inhibitor 1 | Inhibitor | 99.38% | Unkown |
| HY-158979 | Nav1.8-IN-14 | Inhibitor | 99.83% | Unkown |
| HY-160591 | Nav1.8-IN-10 | Inhibitor | / | Unkown |
| HY-160593 | Nav1.8-IN-12 | Inhibitor | / | Unkown |
| HY-163855 | KGP-25 | Inhibitor | 95.0% | Unkown |
| HY-172903 | Nav1.8-IN-16 | Inhibitor | / | Unkown |
| HY-172933 | Nav1.8 modulator 1 | Modulator | / | Unkown |
| HY-17429S | Flecainide-d4 acetate | Inhibitor | 99.0% | Unkown |
| HY-176911 | Nav1.8-IN-21 | Inhibitor | / | Unkown |
| HY-19366 | Nav1.7-IN-2 | Inhibitor | 98.28% | Unkown |
| HY-P1221 | ProTx II | Inhibitor | 98.34% | Unkown |
| HY-P1443 | OD1 | Modulator | 99.40% | Unkown |
| HY-P5160A | Phlotoxin-1 TFA | Inhibitor | 92.73% | Unkown |
| HY-P5786 | Heteropodatoxin-1 | / | Unkown | |
| HY-RS09046 | NAV1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-123833 | PF-05661014 | Modulator | 99.56% | Unkown |
| HY-102998 | Nav1.7-IN-6 | Inhibitor | / | Unkown |
| HY-108425 | AMG8379 | Antagonist | / | Unkown |
| HY-126291 | GNE-616 | Inhibitor | / | Unkown |
| HY-183566 | MK-5661 | Inhibitor | / | Unkown |
| HY-W052508S | Norquetiapine-d8 | / | Unkown | |
| HY-108425A | AMG8380 | Inhibitor | / | Unkown |
| HY-116137 | Nav1.7-IN-17 | / | Unkown | |
| HY-117714 | AZD-3161 | Inhibitor | / | Unkown |
| HY-118952 | PF-06456384 | Inhibitor | / | Unkown |
| HY-120774 | GS-462808 | Inhibitor | / | Unkown |
| HY-126005 | VGSC blocker-1 | Inhibitor | / | Unkown |
| HY-12883B | PF 05089771 tosylate | Inhibitor | / | Unkown |
| HY-132133 | Nav1.8-IN-1 | Inhibitor | / | Unkown |
| HY-135495 | AM-0466 | Inhibitor | / | Unkown |
| HY-138816 | Nav1.7-IN-15 | Antagonist | / | Unkown |
| HY-141547 | Nav1.7-IN-8 | Inhibitor | / | Unkown |
| HY-149944 | Analgesic agent-2 | Inhibitor | / | Unkown |
| HY-149994 | DS43260857 | Inhibitor | / | Unkown |
| HY-155236 | Ancistrotecine B | Inhibitor | / | Unkown |
| HY-159094 | Nav1.8-IN-15 | Inhibitor | / | Unkown |
| HY-160588 | Nav1.8-IN-7 | Inhibitor | / | Unkown |
| HY-160589 | Nav1.8-IN-8 | Inhibitor | / | Unkown |
| HY-160592 | Nav1.8-IN-11 | Inhibitor | / | Unkown |
| HY-160663 | Nav1.7 blocker 1 | / | Unkown | |
| HY-161272 | Nav1.8-IN-6 | Inhibitor | / | Unkown |
| HY-161572 | Nav1.8-IN-13 | Inhibitor | / | Unkown |
| HY-162246 | Nav1.8-IN-5 | Inhibitor | / | Unkown |
| HY-162347 | Nav1.7-IN-13 | Inhibitor | / | Unkown |
| HY-162757 | Anticonvulsant agent 5 | Modulator | / | Unkown |
| HY-167852 | GX-585 | Inhibitor | / | Unkown |
| HY-169421 | Nav1.7-IN-18 | Inhibitor | / | Unkown |
| HY-170930 | Anticonvulsant agent 9 | / | Unkown | |
| HY-171778 | QLS-81 | Inhibitor | / | Unkown |
| HY-172998 | Nav1.8-IN-18 | Inhibitor | / | Unkown |
| HY-172999 | Nav1.8-IN-19 | Inhibitor | / | Unkown |
| HY-174845 | Nav1.8-IN-20 | Inhibitor | / | Unkown |
| HY-175289 | hERG-IN-3 | Inhibitor | / | Unkown |
| HY-176065 | Nav1.2-IN-1 | Inhibitor | / | Unkown |
| HY-178344 | Multi-target kinase-IN-6 | Activator | / | Unkown |
| HY-178963 | Nav1.2-IN-2 | Inhibitor | 99.82% | Unkown |
| HY-179445 | Nav1.7-IN-20 | Inhibitor | / | Unkown |
| HY-181063 | Nav1.5-IN-1 | Inhibitor | / | Unkown |
| HY-181615 | Nav1.8-IN-22 | Inhibitor | / | Unkown |
| HY-182334 | azo-Q2a | Inhibitor | / | Unkown |
| HY-182710 | DA-0218 | Inhibitor | / | Unkown |
| HY-182831 | Nav1.7-IN-22 | Inhibitor | / | Unkown |
| HY-183646 | Nav1.8-IN-23 | Inhibitor | / | Unkown |
| HY-183709 | Nav1.8-IN-24 | Inhibitor | / | Unkown |
| HY-184190 | ERG-IN-7 | Inhibitor | / | Unkown |
| HY-185333 | Sodium Channel-IN-7 | Inhibitor | / | Unkown |
| HY-B0262S | Methocarbamol-d5 | Inhibitor | / | Unkown |
| HY-B0262S2 | Methocarbamol-13C,d3 | Inhibitor | / | Unkown |
| HY-B1837S | Cyfluthrin-d6 | Inhibitor | / | Unkown |
| HY-P10234 | Poneratoxin | Modulator | / | Unkown |
| HY-P11045 | JNJ63955918 | Inhibitor | / | Unkown |
| HY-P1218 | Phrixotoxin 3 | Inhibitor | / | Unkown |
| HY-P1218A | Phrixotoxin 3 TFA | Inhibitor | / | Unkown |
| HY-P1219 | Jingzhaotoxin-III | Inhibitor | / | Unkown |
| HY-P1220 | Huwentoxin-IV | Inhibitor | / | Unkown |
| HY-P1681 | GpTx-1 | Antagonist | / | Unkown |
| HY-P5152 | Scorpion toxin Tf2 | Activator | / | Unkown |
| HY-P5153 | ProTx-III | Inhibitor | / | Unkown |
| HY-P5160 | Phlotoxin-1 | Inhibitor | / | Unkown |
| HY-P5164 | GrTx1 | Inhibitor | / | Unkown |
| HY-P5177 | GsAF-II | Inhibitor | / | Unkown |
| HY-P5781 | δ-Theraphotoxin-Hm1b | Inhibitor | / | Unkown |
| HY-P5782 | δ-Theraphotoxin-Hm1a toxin | Activator | / | Unkown |
| HY-P5783 | δ-Buthitoxin-Hj2a | Agonist | / | Unkown |
| HY-P5784 | δ-Buthitoxin-Hj1a | Agonist | / | Unkown |
| HY-P5790 | μ-TRTX-Hd1a | Inhibitor | / | Unkown |
| HY-P5793 | GTx1-15 | Inhibitor | / | Unkown |
| HY-P5795 | GsAF-I | Inhibitor | / | Unkown |
| HY-P5800 | Phlo1b | Inhibitor | / | Unkown |
| HY-P5801 | Phlo1a | Inhibitor | / | Unkown |
| HY-P5807 | Cn2 toxin | Activator | / | Unkown |
| HY-P5809 | Pe1b | Inhibitor | / | Unkown |
| HY-P5810 | Ceratotoxin-2 | Inhibitor | / | Unkown |
| HY-P5811 | Ceratotoxin-1 | Inhibitor | / | Unkown |
| HY-P5813 | Cd1a | Inhibitor | / | Unkown |
| HY-P5865 | Tap1a | Inhibitor | / | Unkown |
| HY-P5872 | Jingzhaotoxin XI | Inhibitor | / | Unkown |
| HY-P5900 | m3-Huwentoxin IV | Inhibitor | / | Unkown |
| HY-P5916 | VSTx-3 | Antagonist | / | Unkown |
| HY-W031620 | VGSCs-IN-1 | Inhibitor | 99.92% | Unkown |
| HY-W040171 | Tefluthrin | Activator | / | Unkown |
| HY-W699451 | MTSET chloride | Inhibitor | / | Unkown |
| HY-116194 | NaV1.7 blocker-801 | Inhibitor | / | Unkown |
| HY-118048 | NAV 26 | Inhibitor | 99.79% | Unkown |
| HY-17355BS | Dexpramipexole-d3 dihydrochloride | / | Unkown | |
| HY-175226 | DPP8/9-IN-2 | Inhibitor | / | Unkown |
| HY-182195 | Suzetrigine N-oxide | Inhibitor | / | Unkown |
| HY-185334 | GNE-3565 | Inhibitor | / | Unkown |
| HY-185335 | Sodium Channel-IN-8 | Inhibitor | / | Unkown |
| HY-B0262S1 | Methocarbamol-d3 | Inhibitor | 98.15% | Unkown |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990503 | Anti-SCN9a/Nav1.7 Antibody | Inhibitor | 98.57% | Unkown |
| HY-P990502 | Anti-SCN11a/Nav1.9 Antibody | Inhibitor | / | Unkown |